Department of Diagnostic Radiology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.
Duke-NUS Medical School, Singapore, Singapore.
Osteoporos Int. 2019 Dec;30(12):2417-2428. doi: 10.1007/s00198-019-05067-7. Epub 2019 Aug 21.
Understanding the natural history of lateral femoral stress fractures helps to guide their management. Improvement in their radiographic characteristics is rare. Progression was generally sequential, most developing an incomplete fracture line before fracture displacement. Stopping bisphosphonates decreased the fracture rate, a feasible management option for lesions without incomplete fracture lines.
Retrospective study evaluating the natural history of lateral femoral stress fractures (FSF) by serial radiography over a variable period of time in a cohort of patients treated for some time with bisphosphonates for osteoporosis, whilst also identifying the fracture response in cases where bisphosphonates were discontinued.
The radiographs of 76 consecutive patients (92 femurs) with 161 FSF were reviewed to document their change over time. Femurs were classified into the following: A-normal, B-focal cortical thickening, C-dreaded black line and D-displaced fracture. Bisphosphonate history was recorded.
66.5% FSF showed group stability between the first and last radiographs: group B (79.1%), group C (45.7%). 28.6% progressed, mostly following an ordered sequence starting from group A, progressing to B, then C, before culminating in D. Progression rate was as follows: A-100% (11/11), B-18.3% (21/115), C-40% (14/35). Regression in FSF was uncommon-5.6% (8/161). 34.8% (32/92) sustained displaced fractures. Kaplan-Meier analysis showed statistically significant difference between the groups; median survival (95% CI): A-4189 (-), B-3383.0 (-), C-1807 (0.0-3788.6) and progression to displaced fracture when bisphosphonate had been stopped for at least 6 months. The group without recent bisphosphonates had a lower group progression rate (17.1%, 12/70). Nevertheless, 10.9% (5/46) progressed to displaced fracture. This group also had the highest proportion of stable (77.1%, 54/70) and regressive lesions (5.7%, 4/70).
In FSF, there is natural progression from normal bone, to focal cortical thickening, to dreaded black line and eventually to displaced fracture. Most lesions persist, remaining static or progressing, especially if a dreaded black line is present and bisphosphonates are continued. Regression is uncommon and more frequent when bisphosphonates are discontinued. Despite stopping bisphosphonates, there remains a 10.9% risk of progression to displaced fracture.
通过对一组接受一段时间双膦酸盐治疗骨质疏松症的患者的连续影像学检查,评估外侧股骨应力性骨折(FSF)的自然病程,并确定在停止使用双膦酸盐的情况下骨折的反应。
回顾性分析了 76 例(92 侧股骨)连续接受治疗的患者的影像学资料,共 161 例 FSF。记录股骨的变化情况。股骨分为以下几类:A-正常,B-局限性皮质增厚,C-恐怖黑线,D-移位骨折。记录双膦酸盐的使用情况。
66.5%的 FSF 在第一次和最后一次影像学检查之间保持稳定:B 组(79.1%),C 组(45.7%)。28.6%的患者进展,大多数是从 A 组开始,进展到 B 组,然后到 C 组,最终发展到 D 组。FSF 的进展率如下:A-100%(11/11),B-18.3%(21/115),C-40%(14/35)。FSF 很少出现消退-5.6%(8/161)。34.8%(32/92)发生移位骨折。Kaplan-Meier 分析显示,各组之间存在统计学差异;中位生存时间(95%CI):A-4189(-),B-3383.0(-),C-1807(0.0-3788.6),停止使用双膦酸盐至少 6 个月后进展为移位骨折。最近未使用双膦酸盐的组进展率较低(17.1%,12/70)。然而,仍有 10.9%(5/46)的患者进展为移位骨折。该组中稳定(77.1%,54/70)和消退病变(5.7%,4/70)的比例也最高。
在 FSF 中,从正常骨到局限性皮质增厚,再到恐怖黑线,最终到移位骨折,存在自然进展过程。大多数病变持续存在,保持静止或进展,特别是存在恐怖黑线且继续使用双膦酸盐的情况下。消退很少见,在停止使用双膦酸盐时更为常见。尽管停止使用双膦酸盐,但仍有 10.9%的患者进展为移位骨折的风险。